d,l-Fenfluramine response in impulsive personality disorder assessed with [18F]fluorodeoxyglucose positron emission tomography

Neuropsychopharmacology

Volumn 20, Issue 5, 1999, Pages 413-423

  Siever, Larry J ^a   Buchsbaum, Monte S ^a   New, Antonia S ^a   Spiegel Cohen, Jacqueline ^a   Wei, Tsechung ^a   Hazlett, Erin A ^a   Sevin, Elizabeth ^a   Nunn, Melissa ^a   Mitropoulou, Vivian ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Aggression; Glucose metabolic rate; Magnetic resonance imaging; Orbital cortex; Prolactin; Serotonin

Indexed keywords

FENFLURAMINE; PLACEBO; PROLACTIN; SEROTONIN;

ADULT; AFFECTIVE NEUROSIS; AGGRESSION; ARTICLE; CINGULATE GYRUS; CLINICAL ARTICLE; COMPULSIVE PERSONALITY DISORDER; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE; ORAL DRUG ADMINISTRATION; ORBITAL CORTEX; PRIORITY JOURNAL;

ADULT; AGGRESSION; BRAIN CHEMISTRY; BRAIN MAPPING; FEMALE; FENFLURAMINE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; PERSONALITY DISORDERS; PSYCHIATRIC STATUS RATING SCALES; RADIOPHARMACEUTICALS; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033136657     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(98)00111-0     Document Type: Article

References (48)

1. Åsberg M., Schalling D., Träskman-Bendz L., Wägner A. Psychobiology of suicide, impulsivity, and related phenomena. Meltzer H.Y. Psychopharmacology. Third Generation of Progress:1987;655-668 Raven Press, New York.
2. Åsberg M., Schalling D., Träskman-Bendz L., Thorén P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor Arch Gen Psychiatry. 33:1976;1193-1197.
3. Balcioglu A., Wurtman R. Dexfenfluramine enhances striatal dopamine release in conscious rats via serotonergic mechanism. J Pharm and Exper Therapeutics. 284(3):1998;991-997.
4. Baumgarten H., Lachenmayer L. Anatomical features and physiological properties of central serotonin neurons. Pharmacopsychiatry. 18(2):1985;180-187.
5. Baxter L.R., Schwartz J.M., Phelps M.E. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry. 46:1989;243-250.
6. Bremner J.D., Innis R.B., Salomon R.M., Staib L.H., Ng C.K., Miller H.L., Bronen R.A., Krystal J.H., Duncan J., Rich D., Price L.H., Malison R., Dey H., Soufer R., Charney D.S. Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch Gen Psychiatry. 54(4):1997;364-374.
7. Brown G.L., Ebert M.H., Goyer P.F., Jimerson D.C., Klein W.J., Bunney W.E., Goodwin F.K. Aggression, suicide, and serotonin. Relationships to CSF amine metabolites Am J Psychiatry. 139:1982;741-746.
8. Buchsbaum M.S., Wu J., Siegel B., Hackett E., Trenary M., Abel L., Reynolds C. Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiatry. 41:1997;15-22.
9. Buchsbaum M.S., Hazlett E.A. Positron emission tomography studies of abnormal glucose metabolism in schizophrenia. Schizophr Bull. 24:1998;343-364.
10. Chase T.H., Shoulson I. Behavior and biochemical effects of fenfluramine in patients with neurologic disease. Postgrad Med J. 51:1975;105-109.
11. Coccaro E.F., Siever L.J., Klar H., Maurer G., Cochrane K., Cooper T.B., Mohs R.C., Davis K.L. Serotonergic studies in patients with affective personality disorders. correlates with suicidal and impulsive-aggressive behavior Arch Gen Psychiatry. 46:1989;587-599.
12. Coccaro E.F., Kavoussi R.J., Cooper T.B., Hauger R.L. Hormonal responses to d- and d,l-fenfluramine in healthy human subjects. Neuropsychopharmacology. 15:1996;595-607.
13. Damasio A.R., van Hoesen G.W. Emotional disturbances associated with focal lesions of the limbic frontal lobe. Heilman K.M., Satz P. Neuropsychology of Human Emotion. 1983;Guilford Press, New York.
14. Damasio H., Grabowski T., Frank R., Galaburda A., Damasio A.R. The return of Phineas Gage. Clues about the brain from the skull of a famous patient Science. 264:1994;1102-1105.
15. First M., Spitzer R., Gibbon M., Williams J. Structured Clinical Interview for Axis I Disorders - Patient. 1996;NYS Psychiatric Institute, New York.
16. Friston K.J. Commentary and opinion II. Statistical parametric mapping (Ontology and current issues) J Cerebral Blood Flow Metab. 15:1995;361-370.
17. Freo U., Ricchieri G.L., Holloway H.W., Soncrant T.T. Time- and dose-dependent effects of the serotonergic agent quipazine on regional cerebral metabolism in rats. Brain Res. 600:1993;249-256.
18. Goyer P.F., Andreason P.J., Semple W.E., Clayton A.H., King A.C., Compton-Toth B.A., Schulz S.C., Cohen R.M. Positron-emission-tomography and personality disorders. Neuropsychopharmacology. 10:1994;21-28.
19. Grafman J., Schwab K., Warden D., Pridgen A., Brown H., Salazar A. Frontal lobe injuries, violence, and aggression. A report of the Vietnam head injury study Neurology. 46:1996;1231-1238.
20. 1A partial agonists gepirone, ipsapirone and buspirone on local cerebral glucose utilization in the conscious rat. Psychopharmacology. 106:1992;97-101.
21. Hamilton M. Rating scale for depression. J Neurol Neurosurg Psychiatry. 23:1960;56-62.
22. Heinrichs W. Frontal cerebral lesions and violent incidents in chronic neuropsychiatric patients. Biol Psychiatry. 25:1989;174-178.
23. Haznedar M.M., Buchsbaum M.S., Metzger M., Solimando A., Spiegel-Cohen J., Hollander E. Anterior cingulate gyrus volume and glucose metabolism in autistic disorder. Am J Psychiatry. 154:1997;1047-1050.
24. Hommer D., Andreason P.J., Rio D., Williams W., Ruttimann U.E., Momenan R., Zametkin A.J., Rawlings R., Linnoila M. Effects of m-chlorophenylpiperazine on regional brain glucose utilization. A positron emission tomographic comparison of alcoholic and control subjects J Neurosci. 17:1997;2796-2806.
25. Kapur S., Meyer J., Wilson A.A., Houle S., Brown G.M. Modulation of cortical neuronal activity by a serotonergic agent. A PET study in humans Brain Res. 646:1994;292-294.
26. Linnoila M., Virkkunen M., Scheinin M., Nuutila A., Rimon R., Goodwin F.K. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci. 33:1983;2609-2614.
27. Mann J.J., Malone K., Diehl D.J., Perel J., Cooper T.D., Mintum M.A. Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. Am J Psychiatry. 153:1996;174-182.
28. Matsui T., Hirano A. Atlas of the Human Brain for Computerized Tomography. 1978;Igaku-Shoin, Tokyo.
29. 15O]-PET. Biol Psychiatry. 39:1996;516.
30. Moss H.B., Yao J.K., Panzak G.L. Serotonergic responsivity and behavioral dimensions in antisocial personality disorder. Biol Psychiatry. 28:1990;325-338.
31. Mlczoch J., Weir E., Reeves J., Grover R. Long term effects of the anorectic agent fenfluramine alone and in combination with aminorex on pulmonary and system circulation in the pig. Basic Res Cardiol. 74(3):1979;313-320.
32. New A., Trestman R.L., Benishay D.S., Coccaro E.F., Siever L.J. Self-injurious behavior in personality disorders. Psychiatry Res. 69:1997;17-26.
33. O'Keane V., Maloney E., O'Neil H., O'Connor A., Smith C., Dinan T.G. Blunted prolactin response to d-fenfluramine in sociopathy. Evidence for subsensitivity of central serotonergic function Br J Psychiatry. 160:1992;643-646.
34. Pazos A., Probst A., Palacios J.M. Serotonin receptors in the human brain. IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience. 21:1987;123-139.
35. Pelizzari C.A., Chen G.T., Spelbring D.R., Weichselbaum R.R., Chen C.T. Accurate three-dimensional registration of CT, PET, and/or MRI images of the brain. J Comput Assist Tomogr. 13:1989;20-26.
36. Pfohl B., Blum N., Zimmerman M. Structured Clinical Interview for DSM-IV. 1996;American Psychiatric Press, Washington.
37. Porrino L.J., Goldman-Rakic P.S. Brainstem innervation of prefrontal and anterior cingulate cortex in the rhesus monkey revealed by retrograde transport of HRP. J Comp Neurol. 205:1996;63-76.
38. Raleigh M.I., Brammer G.L. Individual differences in serotonin-2 receptors and social behavior in monkeys. Soc Neurosci Abstr. 19:1993;592.
39. Raine A., Buchsbaum M., Stanley J., Lottenberg S., Abel L., Stoddard J. Selective reductions in prefrontal glucose metabolism in murderers. Biol Psychiatry. 36:1994;365-373.
40. Shihabuddin L, Buchsbaum MS, Hazlett EA, Haznedar MM, Harvey PD, Newman A, Schnur DB, Spiegel-Cohen J, Wei T, Machac J, Knesaurek K, Vallabhojosula S, Singer MB, Ciaravolo TM, Luu-Hsia C (1998): Dorsal striatal size, shape, and metabolic rate in neuroleptic-naive and previously medicated schizophrenic patients performing a verbal learning task. Arch Gen Psychiatry.
41. Siever L.J., Trestman R.L. The serotonin system and aggressive personality disorders. Int Clin Psychopharmacol. 8(Suppl 2):1993;33-39.
42. Spitzer R.L., Endicott J. Schedule for Affective Disorders and Schizophrenia. 1978;NYS Psychiatric Institute, New York.
43. Talairach J., Tournoux P. Co-planar Stereotaxic Atlas of the Human Brain. 1988;Thieme, New York.
44. Virkkunen M., Muutila A., Goodwin F.K., Linnoila M. Cerebrospinal fluid metabolite levels in male arsonists. Arch Gen Psychiatry. 44:1987;241-247.
45. Volkow N.D., Tancredi L. Neural substrates of violent behavior. A preliminary study with positron emission tomography Br J Psychiatry. 151:1987;668-673.
46. Volavka J. Neurological, neuropsychological, and electrophysiological correlates of violent behavior, in Neurobiology of Violence. 1995;American Psychiatric Press, Washington, DC.
47. Weir E., Reeve H., Huang J., Michelakis E., Nelson D., Hampl V., Archer S. Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction. Circulation. 94(9):1996;2216-2220.
48. Yeudall L.T. Neuropsychological assessment of forensic disorders. Can Ment Health. 25:1977;7-15.